MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases - Concepedia

Concepedia

Publication | Closed Access

MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases

12

Citations

45

References

2021

Year

Yuan Shi, Wei He, Ming Zhong, Minhao Yu

InflammationAutoimmune DiseaseImmunologyGastroenterologyInflammatory MarkerUlcerative ColitisMedicineInflammatory Bowel DiseasesInflammatory ArthritisRheumatoid Arthritis

References

	Year	Citations

Page 1